Cambridge, United Kingdom

Jasper Clube

This inventor holds 55 USPTO granted patents and 12 published patent applications and 8 EPO patents, primarily in Precision Medicine (CPC class C07K). Top assignees: Kymab Limited, Domantis Limited. Active years: 2014-2023.

USPTO Granted Patents = 55 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.4

ph-index = 15

Forward Citations = 569(Granted Patents)

Forward Citations (Not Self Cited) = 457(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Cholesterol Treatment
Neurodegenerative Diseases
PCSK9 Variants
Immunoglobulin Diversity
Transgenic Vertebrates
Anti-PD-L1 Antibodies
VEGF-A Variants
Pain Treatment
Cancer Therapies
Multi-Antibody Therapeutics
Animal Models
Therapeutic Molecules
55 patents (USPTO):Explore Patents

Title: Jasper Clube: Innovator Extraordinaire and Patent Wizard

Introduction:

Meet Jasper Clube, a brilliant inventor hailing from Cambridge, United Kingdom. With an impressive count of 55 patents under his belt, Clube has made significant contributions to the fields of healthcare and precision medicine. His revolutionary inventions have not only tackled challenging health conditions but have also paved the way for more efficient treatment methods. Let's delve deeper into some of Clube's groundbreaking patents and delve into his professional journey.

Anaemia Treatment and Prevention:

One fascinating patent developed by Jasper Clube revolves around treating or preventing anaemia in mammals and humans. Thriving in the area of moderate to severe anaemia, Clube's invention offers solutions to sparing the administration of erythropoiesis stimulating agents (ESAs) to patients. By addressing this targeted condition, Clube's innovative approach could potentially alleviate the burden on patients and provide more personalized treatment avenues.

Precision Medicine for Cholesterol Treatment:

Clube's ingenuity extends to the realm of precision medicine with a patent focused on cholesterol treatment. His invention centers on identifying human targets of interest (TOI), developing anti-TOI ligands, and creating kits and compositions for efficient cholesterol management. Clube's remarkable contribution in this area lays the foundation for potential breakthroughs in personalized and tailored cholesterol treatment plans.

Professional Journey:

Throughout his career, Jasper Clube has collaborated with renowned companies to bring his inventive ideas to life. He has notably worked with Kymab Limited, a pioneering biotechnology company based in Cambridge, and Domantis Limited, an innovative firm specializing in the development of therapeutic products. Clube's partnerships with these esteemed organizations speak volumes about his expertise and dedication in the field of innovation.

Colleague Collaborations:

Clube's innovative spirit has also thrived through collaborations with brilliant minds in his field. Noteworthy colleagues include E-Chiang Lee and Allan Bradley, whose contributions have undoubtedly augmented Clube's inventions. These collaborative efforts reinforce the importance of knowledge exchange and multidisciplinary approaches in advancing scientific breakthroughs.

Conclusion:

Jasper Clube stands as a prime example of an innovator and patent wizard. His extensive patent portfolio in the areas of anaemia treatment, precision medicine, and cholesterol management highlights his profound impact on the healthcare industry. Clube's collaborations with esteemed companies and colleagues further solidify his status as a visionary inventor. As the world eagerly awaits Clube's next invention, his remarkable contributions continue to shape the realm of innovations and patents.

For more articles on fascinating inventors and cutting-edge patents, visit our website idiyas.com, your go-to resource for all things innovation and intellectual property.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…